Background: Asthma has been linked to stroke, but it is unknown if hay fever is related to stroke. This study was designed to investigate if there is an association between a reported history of hay fever and stroke during a 4.4-year study period.
Stroke is the third leading cause of death in the United States. 1 Established risk factors include smoking, hypertension, diabetes, and obesity; however, the occurrence of stroke is not fully explained by these factors alone. 2 Recent research into the pathophysiology of stroke has demonstrated a possible role for increased systemic inflammation that may lead to cerebrovascular thrombotic events and stroke. [3] [4] [5] Chronic inflammation from respiratory conditions may follow a similar association with stroke. One study 6 found that middle age and elderly patients who reported a history of asthma had an increased risk of stroke over 14 years. Asthma and chronic hay fever share some similar pathophysiology with chronic inflammation. Thus, the presence of hay fever may contribute to an increased risk of stroke in a similar fashion as asthma through a combination of elevated blood pressure and inflammation. Considering there are an estimated 20 million adults affected by hay fever in the United States, this study was initiated to examine the association between hay fever and stroke. 
Methods

Study Population
We undertook an analysis of the Atherosclerosis Risk in Communities Study (ARIC) public use data set, a prospective cohort performed in Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and the suburbs of Minneapolis, Minnesota. 8 The original cohort consisted of 15,792 participants who were enrolled in the ARIC study between 1987 and 1989. At the time of their first visit, the participants were between the ages of 45 and 64. Monitoring has consisted of periodic history and physical examination, annual telephone calls, and hospital discharge and death certificate surveillance.
For the purposes of this study, we performed an analysis using information from the participants' fourth visit (1996 to 1998; visit 4) as our baseline because this is the only visit in which participants were questioned about a history of hay fever. Participants were followed through 31 December 2001. We excluded patients with a history of stroke or coronary heart disease because of their high risk of stroke. 2 Because asthma and hay fever seem to have a similar pathophysiology, we initially performed an analysis that excluded asthma participants. We then performed an analysis that included participants with asthma to determine whether asthma may be an effect modifier or a confounding variable.
Definition of Hay Fever
For purposes of our study, hay fever was defined as a report by a participant of ever having been told by a physician that he or she had hay fever. We relied on participants' self-reporting of hay fever because formal allergy skin testing was not available in the ARIC dataset. We used the term hay fever rather than allergic rhinitis because it was the term used by the ARIC interviewers. Because of the seasonal nature of hay fever, we included participants who ever reported hay fever rather than only participants who were suffering with hay fever at the time of visit 4.
Determination of Stroke Events
The methods used in the ARIC study for evaluating stroke have been extensively outlined by Rosamond et al. 9 Three methods were used to determine the incidence of stroke. First, yearly interviews were conducted with participants by telephone. Second, the records of local hospitals were reviewed for admissions of study participants during the previous year. Third, death certificates were reviewed from the vital statistics offices in the states involved in the study. In the analysis of hospital records, strokes were identified based on ICD-9 discharge codes 430 through 438, which encompass the different stroke subtypes. In addition, strokes were identified if there was a mention of stroke in a radiologic report. This information was abstracted by a trained nurse who reviewed the hospital discharge records. Stroke cases were initially classified by a computer algorithm and then were confirmed by an expert reviewer based on criteria taken from the National Survey of Stroke. 10 Discrepancies between the computer and the expert reviewer were settled by another expert reviewer. Strokes were then further stratified as "possible," "definite," or "probable" based on radiologic imaging and autopsy, if available. 11 We included stroke events classified as either definite or probable. Strokes were also defined as ischemic or hemorrhagic but, because of the small number of hemorrhagic strokes (17 out of 125), we used both ischemic and hemorrhagic strokes for our stroke events without differentiating between the 2 types. We also performed an analysis of ischemic strokes alone.
Control Variables
Several variables have been identified as risk factors for stroke and thus may be potential confounders of any relationship between hay fever and stroke. These include sex, race, smoking, body mass index, diabetes, hypertension, alcohol consumption, asthma, and hyperlipidemia.
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Analysis
We used the statistical package SAS (Statistical Analysis System, Cary, NC) for all analyses. We used 2 tests to examine, for each of the control variables, the bivariate relationships between participants with and without a history of hay fever. We computed an unadjusted Cox regression to determine the relationship between hay fever and risk of future stroke. Two multivariate Cox regressions were performed: one with adjustment for age and smoking because those 2 variables were significant in bivariate analysis; and one including all pre-specified control variables. In addition to our primary analysis we conducted a further analysis to determine whether participants with a history of hay fever and antihistamine usage, a possible proxy for severity of hay fever, were at greater risk of stroke than participants with a history of hay fever who did not use antihistamines. We determined if the participants used antihistamines based on the medical history obtained during visit 4.
Results
Our cohort consisted of 9272 eligible participants at baseline, with a mean follow-up of 4.4 years and an average age of 62.4 years. There were 125 definite or probable strokes during follow-up, and 10.4% of the cohort had a previous diagnosis of hay fever. In bivariate relationships, age and smoking were significantly different between the hay fever and non-hay fever groups (Tables 1 and 2 ). Younger participants and those who did not smoke had more hay fever.
Of those with hay fever, 2.2% had stroke compared with 1.25% of those without hay fever (P ϭ .02). The adjusted hazard ratios (HRs) show that a history of hay fever is a significant risk factor for the development of stroke even after controlling for relevant confounding variables (Table 3) . We performed an adjusted Cox's regression of combined ischemic and hemorrhagic strokes excluding asthmatics, which demonstrated that participants with hay fever had a much greater risk of stroke than those without hay fever (HR, 1.87; 95% CI, 1.17-2.99). We then performed an adjusted Cox's regression of study participants for combined ischemic and hemorrhagic strokes including asthmatics and found that participants with hay fever had a significantly greater risk of stroke than those without hay fever (HR, 1.83; 95% CI, 1.18 -2.84), even when we controlled for the aforementioned covariates as well as asthma. We then performed an adjusted Cox's regression for only ischemic strokes that excluded asthmatics and that showed participants with hay fever had a significantly greater risk of ischemic stroke than those without hay fever (HR, 1.72; 95% CI, 1.03-2.90). Finally, we examined antihistamine use as a possible proxy for the severity of hay fever. In an adjusted Cox's regression, with no hay fever and no antihistamine use as the reference category, the risks progressed from no hay fever and some antihistamine use (HR, 1.02; 95% CI, 0.41-2.51) to hay fever and no antihistamine use (HR, 1.76; 95% CI, 1.05-2.95) to hay fever and some antihistamine use (HR, 2.50; 95% CI, 0.92-6.83).
Discussion
The primary finding of this study is that patients with a history of hay fever have a higher risk of The results of this study indicate that hay fever is an independent risk factor for first stroke. Furthermore, patients with hay fever who use antihistamines may be at particularly great risk. Whether this is caused by more severe hay fever or some iatrogenic response to antihistamines is unclear. Hay fever, which has previously been viewed as a benign condition, may be a contributor to cerebrovascular risk. Because over 8.6% of the United States population suffers from hay fever, this study's findings may have broad public health implications regarding who may be at risk of stroke and may increase the need for risk factor modification in people suffering from chronic allergy symptoms. 18 One mechanism by which the risk of stroke may be increased is through hypertension induced by hay fever. 19, 20 Our analysis, however, suggests that the association between hay fever and stroke remained even after controlling for diagnosed hypertension.
Hay fever is a disease associated with systemic inflammation. During a typical allergy attack, inflammatory mediators such as histamine, leukotrienes, prostaglandins, and cytokines are released. As such, it may be this systemic inflammation that increases the risk of stroke. The findings of this study are in line with other studies involving participants with respiratory conditions and potential inflammation. For example, Low et al 21 showed that upper respiratory infections, grass pollen, and air pollutants led to increased hospital admissions for stroke.
This study has a few limitations of note. For the determination of hay fever, patients were identified by self-report rather than formal allergy skin testing. Specifically, the participants were asked if a physician had ever diagnosed them with hay fever. We can estimate, however, that 80% of patients who are identified as having allergies by a physician will have a positive allergy skin test. 22, 23 Furthermore, the number of affected participants in our dataset is consistent with the 2002 Chartbook on Trends in the Health of Americans, 18 which found that in patients ages 45 to 64 the prevalence of hay fever was 10.8%.
In conclusion, a history of hay fever seems to be a risk factor for stroke, and this association may be an area for future research and intervention.
